Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 5
2020 5
2021 8
2022 6
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results.
Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL, Galloway DA, Pinder LF, Donnell D, N Wakhungu I, Biwott C, Kimanthi S, Heller KB, Kanjilal DG, Pacella D, Morrison S, A Rechkina E, L Cherne S, Schaafsma TT, McClelland RS, Celum C, Baeten JM, Mugo NR; KEN SHE Study Team. Barnabas RV, et al. Nat Med. 2023 Dec;29(12):3224-3232. doi: 10.1038/s41591-023-02658-0. Epub 2023 Dec 4. Nat Med. 2023. PMID: 38049621 Free PMC article. Clinical Trial.
Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya.
Haberer JE, Mugo N, Bukusi EA, Ngure K, Kiptinness C, Oware K, Garrison LE, Musinguzi N, Pyra M, Valenzuela S, Thomas KK, Anderson PL, Thirumurthy H, Baeten JM. Haberer JE, et al. Among authors: kiptinness c. J Acquir Immune Defic Syndr. 2022 Mar 1;89(3):251-260. doi: 10.1097/QAI.0000000000002876. J Acquir Immune Defic Syndr. 2022. PMID: 35147580 Free PMC article.
Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial.
Ortblad KF, Bardon AR, Mogere P, Kiptinness C, Gakuo S, Mbaire S, Thomas KK, Mugo NR, Baeten JM, Ngure K. Ortblad KF, et al. Among authors: kiptinness c. JAMA Netw Open. 2023 Jun 1;6(6):e2318590. doi: 10.1001/jamanetworkopen.2023.18590. JAMA Netw Open. 2023. PMID: 37318803 Free PMC article. Clinical Trial.
Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention.
Ngure K, Mugo NR, Bukusi EA, Kiptinness C, Oware K, Gakuo S, Musinguzi N, Pyra M, Garrison L, Baeten JM, Haberer JE. Ngure K, et al. Among authors: kiptinness c. J Acquir Immune Defic Syndr. 2021 Dec 1;88(4):e30-e32. doi: 10.1097/QAI.0000000000002793. J Acquir Immune Defic Syndr. 2021. PMID: 34446676 Free PMC article. No abstract available.
Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
Kiptinness C, Naik P, Thuo N, Malen RC, Dettinger JC, Pintye J, Rafferty M, Jomo E, Nyamasyo N, Wood T, Isabelli P, Morris S, Hattery D, Stergachis A, Were D, Sharma M, Ngure K, Mugambi ML, Ortblad KF. Kiptinness C, et al. Front Public Health. 2023 Feb 24;11:1054559. doi: 10.3389/fpubh.2023.1054559. eCollection 2023. Front Public Health. 2023. PMID: 36908449 Free PMC article.
36 results